Trials / Not Yet Recruiting
Not Yet RecruitingNCT07031141
Diabetes Foot Africa Region Registry
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Getz Pharma · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
D-FAR is to gather robust data on the clinical characteristics, management, and outcomes of patients with diabetic foot complications to enhance understanding, reduce complications, and improve patient care. This will include insights into the prevalence of risk factors, adherence to treatment protocols, and the effectiveness of interventions aimed at reducing the incidence of amputations and other adverse outcomes.
Detailed description
Among the various complications, those related to diabetic foot disease are associated with the highest morbidity and mortality. Diabetic foot problems are characterized by infection, ulceration and/or destruction of deep tissue in the foot and are usually associated with neurological abnormalities and varying degrees of peripheral arterial disease (PAD) in the lower limb. the purpose of collect comprehensive data on the clinical features, management strategies, and outcomes of patients with diabetic foot complications.
Conditions
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2025-06-22
- Last updated
- 2025-06-22
Source: ClinicalTrials.gov record NCT07031141. Inclusion in this directory is not an endorsement.